Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas T Yamauchi, M Ohno, Y Matsushita, M Takahashi, Y Miyakita, Y Kitagawa, ... Brain tumor pathology 35, 148-158, 2018 | 28 | 2018 |
A novel topical fluorescent probe for detection of glioblastoma Y Kitagawa, S Tanaka, M Kamiya, Y Kuriki, K Yamamoto, T Shimizu, ... Clinical Cancer Research 27 (14), 3936-3947, 2021 | 24 | 2021 |
A new era of neuro-oncology research pioneered by multi-omics analysis and machine learning S Takahashi, M Takahashi, S Tanaka, S Takayanagi, H Takami, ... Biomolecules 11 (4), 565, 2021 | 19 | 2021 |
First case of human neurocoenurosis caused by Taenia serialis: A case report E Yamazawa, M Ohno, K Satomi, A Yoshida, Y Miyakita, M Takahashi, ... International Journal of Infectious Diseases 92, 171-174, 2020 | 16 | 2020 |
MRI-based radiomics differentiates skull base chordoma and chondrosarcoma: a preliminary study E Yamazawa, S Takahashi, M Shin, S Tanaka, W Takahashi, T Nakamoto, ... Cancers 14 (13), 3264, 2022 | 14 | 2022 |
Accurate preoperative identification of motor speech area as termination of arcuate Fasciculus depicted by Q-ball imaging tractography T Koike, S Tanaka, T Kin, Y Suzuki, S Takayanagi, H Takami, ... World Neurosurgery 164, e764-e771, 2022 | 5 | 2022 |
A rare case of brain metastasis from poorly differentiated small bowel adenocarcinoma E Yamazawa, Y Honma, K Satomi, H Taniguchi, M Takahashi, A Yoshida, ... Surgical Neurology International 10, 2019 | 4 | 2019 |
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation S Neyazi, E Yamazawa, K Hack, S Tanaka, G Nagae, C Kresbach, ... Acta neuropathologica 147 (1), 1-18, 2024 | 2 | 2024 |
The ERK inhibitor LY3214996 augments anti-PD-1 immunotherapy in preclinical mouse models of BRAFV600E melanoma brain metastasis MA de Sauvage, C Torrini, E Nieblas-Bedolla, EJ Summers, E Sullivan, ... Neuro-oncology 26 (5), 889-901, 2024 | 1 | 2024 |
DDIS-02. Development of novel spray-type fluorescent probes for glioblastoma detection Y Kitagawa, S Tanaka, Y Kuriki, K Yamamoto, T Nejo, S Takahashi, ... Neuro-Oncology 21 (Supplement_6), vi65-vi65, 2019 | 1 | 2019 |
NIMG-11. VISUALIZATION OF JUDGMENT BASIS OF CNN TO GRADING GLIOMA S Takahashi, S Tanaka, M Takahashi, E Yamazawa, T Hana, Y Kitagawa, ... Neuro-Oncology 21 (Suppl 6), vi163, 2019 | 1 | 2019 |
Multinodular and vacuolating neuronal tumor of the cerebrum の長期経過と文献的考察 山澤恵理香, 大野誠, 里見介史, 吉田朗彦, 宮北康二, 高橋雅道, ... 脳神経外科ジャーナル 28 (1), 27-32, 2019 | 1 | 2019 |
Region‐specific DNA hydroxymethylation along the malignant progression of IDH‐mutant gliomas T Hana, A Mukasa, M Nomura, G Nagae, S Yamamoto, K Tatsuno, ... Cancer Science 115 (5), 1706-1717, 2024 | | 2024 |
Glioblastoma with high O6-methyl-guanine DNA methyltransferase expression are more immunologically active than tumors with low MGMT expression Y Kushihara, S Tanaka, Y Kobayashi, K Nagaoka, M Kikuchi, T Nejo, ... Frontiers in immunology 15, 1328375, 2024 | | 2024 |
EVALUATING THE THERAPEUTIC EFFECTS OF SMALL MOLECULE INHIBITORS OF CDK4/6 AND FAK IN PRECLINICAL MENINGIOMA MODELS N Ijad, K Waller, N Nayyar, E Yamazawa, E Summers, C Migliarese, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
EXTH-42. PRECLINICAL INVESTIGATION OF A NOVEL BRAIN PENETRANT MEK INHIBITOR TO TARGET BRAIN METASTASIS E Yamazawa, N Nayyar, N Ijad, C Torrini, M De Sauvage, C Migliarese, ... Neuro-Oncology 25 (Supplement_5), v233-v234, 2023 | | 2023 |
EXTH-45. DEVELOPMENT OF COMBINATION THERAPIES OF KRASG12C INHIBITOR ADAGRASIB IN PRECLINICAL MODELS OF BRAIN METASTASIS C Torrini, C Migliarese, E Summers, FT Demir, N Ijad, N Nayyar, ... Neuro-Oncology 25 (Supplement_5), v234-v234, 2023 | | 2023 |
CDK4/6 INHIBITION WITH ABEMACICLIB SENSITIZES INTRACRANIAL TUMORS TO CHECKPOINT BLOCKADE IN PRE-CLINICAL MODELS OF BRAIN METASTASIS N Nayyar, M De Sauvage, E Sullivan, J Chuprin, E Yamazawa, B Michael, ... NEURO-ONCOLOGY 24, 98-98, 2022 | | 2022 |
EPEN-27. Epigenetic dissection of spinal ependymomas (SP-EPN) separates tumors with and withoutNF2 mutation S Neyazi, E Yamazawa, C Kresbach, G Nagae, A Eckhardt, T Umeda, ... Neuro-Oncology 24 (Supplement_1), i44-i45, 2022 | | 2022 |
EPCO-01. MOLECULAR PROFILING OF SPINAL CORD EPENDYMOMA E Yamazawa, S Tanaka, G Nagae, T Umeda, T Hana, P Kim, F Higuchi, ... Neuro-Oncology 23 (Supplement_6), vi1-vi1, 2021 | | 2021 |